Beyond the headlines - Actual research within.9 Apr 2024 18:33
From the responses Captain is making I am assuming many are still bleating about CNSLs record of growth as announced in the previous trading update.
As my analysis showed at the time it was largely smoke and mirrors. This was because of the lack of governance in production facilities which meant that yields were significantly down. In English, that means they couldn't invoice (if you don't ship you don't invoice and you don't get paid).
This meant that instead of carrying around a £1m order book into the next financial period as they normally do, they carried £2.4million. As stated when announcing a £2.5m order book in the trading update:
"The current and forecasted orders (my note: £2.5m) are no longer able to be fulfilled before the year end, but will contribute to a stronger than expected opening order book for FY24."
What is the headline constantly being used? Likely this one:
Revenue increased 44% to £4.9m (H1 2022: £3.4m).
This "increase" was purely from Footprint. Food Detective is stagnant as stated in the RNS and confirmed by Jag in call.
So, take the additional circa £1.4m carried due to production yield/governance issues off the sales and you're actually looking at £3.5 million. A c £100K change from H1 2022. Even they state in the Trading Update Sept 23 that the increase was due to improved yields on FoodPrint.
Remember that due to improvements margin has recovered but then costs increased (excluding one offs) by £400,000 in this period. This is important to note for anyone with a historic perspective of ODX.
The board also stated in the update:
"H2 is expected to remain strong, although in the absence of any further backlog to fulfill, is expected to be slightly lower than H1 FY24"
In 2022 sales were £8.5 million
In 2023 sales were £7.5 million (a 12% drop and at the bottom of forecast)
Do you spot it? H2 traditionally produces higher revenue. H2 2022 for example was £5.1m.
To make this simple: H2 will be under £5m meaning the company is not expected to generate more than £10 million in a year. In fact, they admit they won't. Realistically we are going to be looking at a range of £8 to 9.5million and another loss with substantial cost increases due to "headwinds" and higher salary costs. This means that EBITDA will be neutral or negative. Again.
In other words a company with significant challenges in an increasingly competitive market making no progress except slightly recovering from the disaster of last FY. The news on the other items of jam will be of interest and I am sure many will crow on the "increase" in revenue. But it is very thin for anyone interested in this stock beyond the simpletons headlines.
Don't say you weren't warned. DYOR.